It disrupts metastasis by inhibiting the activity of matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, which degrade the extracellular matrix (ECM) and allow cancer cells to invade surrounding tissues and enter the bloodstream [40]. The gene discussed is MMP9; the disease is cancer.